Table 8. Summary of neonate outcomes at birth in the safety population.
| AZCQ (N = 157*) | |
|---|---|
| Number (%) of neonates | |
| Gender | |
| Female | 66 (42.0) |
| Male | 91 (58.0) |
| Birth length (cm) | |
| Mean (SD) | 46.3 (3.6) |
| Range | 29.0–54.0 |
| N | 133 (84.7) |
| Birth weight (g) | |
| Mean (SD) | 3022.3 (494.5) |
| Range | 1200.0–4900.0 |
| N | 137 (87.3) |
| Head circumference (cm) | |
| Mean (SD) | 34.3 (2.2) |
| Range | 24.0–46.0 |
| N | 133 (84.7) |
| APGAR score (5 min) | |
| Mean (SD) | 9.7 (1.2) |
| Range | 1.0–10.0 |
| N | 126 (80.3) |
| Normal newborn** | |
| Yes | 144 (91.7) |
| No | 11 (7.0) |
| Total | 155 |
| Congenital malformation/anomaly | |
| Yes (1 hypospadia, 1 polydactyly) | 2 (1.3) |
| No | 153 (97.5) |
| Unknown | 2 (1.3) |
| Total | 157 |
| Other neonatal problem/abnormality | |
| Yes | 9 (5.7) |
| No | 146 (93.0) |
| Unknown | 2 (1.3) |
| Total | 157 |
AE, adverse event; APGAR, Appearance, Pulse, Grimace, Activity, Respiration; AZCQ, azithromycin-chloroquine; SD, standard deviation.
*N displayed in the table was based on live born infants with either a date of birth or an AE record.
**Newborn without congenital malformations / anomalies and neonatal problems / abnormalities.